-
Most Recent
Cannabis Stocks
Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.
3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030
These are the cannabis stocks to buy as they represent companies with improving fundamentals and accelerated growth outlook.
7 Growth Stocks That Could 7X in the Next 7 Years
Investors consider these growth stocks to buy since they represent companies with good fundamentals and a positive industry outlook.
3 Cannabis Stocks to Sell in August Before They Crash & Burn
Marijuana could be a major industry in the U.S. if it was legalized but these cannabis stocks to sell have other problems to contend with.
Other industries you might be interested in
Recent Cannabis Stocks Articles
Best ETFs for 2020: The Alternative Harvest ETF (MJ) Will Light Up
The Alternative Harvest ETF (MJ) has a shot at being one of the best ETFs next year, as its holdings should bounce off their all-time lows.
3 Excellent Reasons to Be Bullish on Aphria
It’s been horrific for cannabis stocks. But Aphria stock is presenting some interesting opportunities. Here’s a look at this standout company.
Hexo? Heck No! Just Avoid Hexo Stock for Now
I'm still bullish on marijuana stocks, but I won't let Hexo stock weigh down my portfolio.
Tuesday’s Vital Data: Freeport-McMoRan, Canopy Growth and Aurora Cannabis
Options trading was buzzing in Freeport-McMoRan, Canopy Growth and Aurora Cannabis. Here are the metrics that matter moving forward.
Aphria Is Making the Right Moves to Survive Marijuana Slump
The outlook for cannabis stocks remains challenging. But if anyone can turn it around in 2020, it could well be Aphria.
If You Haven’t Ditched NBEV Stock Yet, Now Is the Time
New Age Beverages stock is a multi-level marketing loser. The CEO is selling shares and the company is in debt and losing money.
5 Reasons to Buy Aphria Stock Before Pot Stocks Start Moving Again
Like other Canadian cannabis stocks, APHA stock has taken a beating in recent months as revenue growth has fallen short of expectations. However, there are at least five reasons why Aphria shares could be headed higher soon.
Is the Right Move to Buy Hexo Stock Amid Cannabis Rebound?
Hexo stock is showing improvement on the charts, but we need a significant improvement given the lacking fundamentals and industry disdain.
Cannabis 2.0 Highlights the Rewards — and Risks — of Canopy Growth Stock
Cannabis 2.0 is supposed to give Canopy Growth stock an edge over other cannabis plays. But if Cannabis 2.0 is disappointing, CGC stock will be out of catalysts.
The Outlook of Aurora Stock Is Mixed
Aurora stock is out of favor and is at risk of falling steadily over the next few quarters. But the long-term outlook of ACB stock is upbeat.
A Constellation Buyout Would Harm Canopy Growth Shareholders
Canopy Growth, like other marijuana stocks, continues trending downward. One big factor could prevent it from recovering.
Why Canopy Growth Stock Could Rebound Tremendously in 2020
While 2019 was a rough year for Canopy Growth stock, CGC stock could nearly double in 2020.
Aurora Cannabis Stock Offers Traders Fresh Opportunities
Cannabis stocks are struggling to gain traction but trading opportunities are still available. Aurora stock wants to base to setup rallies.
What the MORE Act Means for Cannabis Stocks
The MORE Act is one of two marijuana bills making their way through Congress. The MORE Act is good news for the legalization effort, but it likely won't be a game-changer for cannabis stocks.
6 Giant Investing Trends for 2020 That You Don’t Want to Miss
These investing trends for 2020 cover trends that will disrupt everything from the housing market to the cars we drive. Don't miss out.
Ignore the Canopy Growth Ambulance Chasers
On Nov. 21, Canopy Growth responded to the potential class-action suits. CGC stock fell on the news. Should shareholders be concerned?
